EDP activities impact the course of atherosclerosis through regulating the levels of the sialylation of CD36, a process largely governed by the ERC and its catalytic subunit, NEU1, to modulate oxLDL uptake in these cells [50]. The gene discussed is NEU1; the disease is atherosclerosis.